MegaLabs ZAO

– Merck and L'Oréal Alum will Help Drive the Company's Continued Growth – MONTVALE, N.J., June 27, 2023 /PRNewswire/ -- Pioneering healthcare communications company Health Monitor Network today announced the hiring of Kelli Vincent-Rodriguez as Senior Vice President for Over-the-Counter/Consumer Packaged Goods (OTC/CPG) clients. In this new leadership role, Kelli will report to Augie Caruso, Executive Vice President of Sales & Key Accounts, to position Health Monitor Network as a trusted partner to OTC/CPG brands as they strengthen their relationships with providers and patients. Kelli will introduce, educate, and recruit OTC/CPG brands to the power of Health Monitor Network's omnichannel platform – 200,000 physician office networks, 450,000 physicians, innovative digital screens, and more – to deliver trustworthy educational content at all points of care. "There is a tremendous opportunity for OTC brands to build trusted relationships with patients and their healthcare providers through content. Health Monitor Network is poised to facilitate these relationships," explained Kelli. "I'm excited to bring my experience in consumer markets and pharmaceuticals together to help OTC brands build awareness and loyalty at the point of care." "We've seen strong demand from OTC/CPG brands as they build true omnichannel marketing campaigns to better engage with healthcare practitioners," said David Paragamian, CEO at Health Monitor Network. "Kelli will accelerate our goal of delivering brand-building solutions for OTC at critical moments and points of care, just as pharmaceutical brands have done with us for decades." Kelli earned her undergraduate degree from Siena College and completed advanced graduate work at Harvard and George Washington University. She brings more than two decades of sales, marketing, and business development experience across OTC, CPG, and pharmaceuticals. At L'Oréal, Kamedis Dermatology, and, most recently, Megalabs USA, she specialized in commercializing new OTC Brands in North America opening new revenue streams and channels – including retail, HCP professional, and e-commerce – leading to significant annual growth. In 2018, she received Healthcare Businesswomen's Leadership Excellence Award, and in 2019, she was honored as one of Drug Store News' Top Women in Health Wellness & Beauty. She started her pharmaceutical career at Schering-Plough (now Merck). She currently serves on the Board of Directors for The Corporate Diwali, a global organization empowering female entrepreneurs, and Healthcare Businesswomen Association, a global professional association committed to furthering the advancement and impact of women in the healthcare business. About Health Monitor Network® Health Monitor is a targeted healthcare marketing platform for the pharmaceutical/OTC and CPG industries. Our in-house, award-winning content studio creates bespoke educational content about disease states and specific therapies that powers more productive patient-physician dialogues. Health Monitor has the largest proprietary physician office network in the industry, with over 200,000 offices and more than 450,000 healthcare professionals engaging with our omnichannel educational products. For 40 years, our brand has been at the forefront of healthcare marketing and trusted to deliver high-value content at all points of care for patients and physicians providing powerful ROI to brands and better outcomes for patients. Together we build brands and empower patients. Learn more at and on LinkedIn and Twitter. SOURCE Health Monitor Network

Wound Healing & Gut Health Supplements Debut at Booth 1339 at NACDS Total Store Expo BOSTON, Aug. 24, 2022 /PRNewswire/ -- Megalabs USA, a subsidiary of Megalabs Inc., that manufactures, markets and distributes pharmaceutical products and nutritional supplements throughout the Americas, has added two new products, Abintra and Glutapak R, to its North American portfolio. These additions join the brand's other science-based nutritional products, which include Enterex Diabetic, a nutritionally complete, high-protein shake specially formulate for for people with diabetes, and Prunelax, a popular lineup of laxative supplements. Megalabs USA CEO Fabian Rivero said the portfolio expansion further supports the company's mission. "We are passionate about creating products that improve the lives of our customers," Rivero said. "These new products offer proven, evidence-based therapies, and I couldn't be prouder to bring them to our North American markets." Abintra is Megalabs USA's nutritional supplement formulated to help heal wounds. Although it's an often-overlooked aspect of wound care, nutrition is a key factor for healing. Abintra features a unique combination of arginine, glutamine, high-quality protein, and antioxidant vitamins and minerals in a quick-dissolving powder. The formula works to promote tissue synthesis and wound healing from within. Glutapak R is a probiotic glutamine supplement for gut health and intestinal healing. Glutapak R is currently the only therapeutic intestinal product on the market that both restores healthy microflora in the gut with a clinically proven probiotic and helps to repair intestinal damage with glutamine. Though the products have just launched, they are already seeing positive reviews, especially among healthcare providers. "As physicians have long known, proper nutrition is a key aspect of wellness," Rivero said. "Products like Abintra and Glutapak R support optimal nutrition in cases when it matters most, which is why we've seen such a positive reception for them within the healthcare community." Abintra and Glutapak R are available on Amazon.com. Glutapak R can also be found at Navarro and other local Miami pharmacies. About Megalabs USA Megalabs USA is a subsidiary of Megalabs, an international pharmaceutical company that manufactures, markets and distributes pharmaceutical products and nutritional supplements throughout the Americas, including the United States and Canada. It distributes over-the-counter products formulated with plant extracts known for their medicinal attributes, combining them with nutraceuticals, vitamins, and minerals to produce highly effective products for various wellness categories. Our mission is to develop and market effective over-the-counter medicines and nutraceuticals, preferably of natural origin, that improve the health and quality of our customers' lives. Company products are readily available in all markets in the Americas through subsidiaries and distributors that are highly committed to our brands, and active in multiple retail channels, including drug, food, mass, and e-commerce. Our vision has led us to build a successful multinational company with leading quality and effective products in the essential categories of over-the-counter medicines and nutraceuticals. And we have achieved this while complying with the exacting standards and procedures required for drug manufacturing to ensure the efficacy and safety of our products. Megalabs USA develops and provides effective, over-the-counter products and supplements that use natural ingredients to improve people's health and quality of life.